Background
Method
Study location
Study population
DNA extraction
CCR5 gene amplification
HIV-V3 region amplification
Sequencing of CCR5 and HIV-V3 gene
Phylogenic analysis
Results
Parameter | Frequency (%) | |||
---|---|---|---|---|
CD4 category | Total | A | B | C |
CD4 ≥ 500 cells/μL | 45 (45) | 43 (95.6) | 2 (4.4) | 0 (0.0) |
CD4 200–499 cells/μL | 41 (41) | 29 (70.7) | 9 (22.0) | 3 (7.3) |
CD4 < 200 cells/μL | 14 (14) | 4 (28.6) | 7 (50.0) | 3 (21.4) |
ART intake | ||||
On ART | 100 (100) | |||
ART Naïve | 0 (100) | |||
Gender | ||||
Male | 35 (35) | |||
Female | 65 (65) | |||
Mode of acquisition | 0 (0) | |||
Vertical | 0 (0) | |||
Blood transfusion | 0 (0) | |||
Sexual | 0 (0) | |||
Not sure | 100 (100) |
SEQ Name | Protein sequence | ||||
1_R5F_H10_22 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
2_R5F_A11_02 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
3_R5F_B11_05 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
5_R5-F_D05_11 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
7_R5-F_F05_17 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
8_R5-F_G05_20 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
9_R5-F_H05_23 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
10_R5-F_A06_03 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
11_R5-F_B06_06 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
12_R5-F_C06_09 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
13_R5-F_D06_12 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
14_R5-F_E06_15 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
15_R5-F_F06_18 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
16_R5-F_G06_21 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
17_R5-F_H06_24 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
18_R5-F_A07_01 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
19_R5-F_B07_04 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
20_R5-F_C07_07 | FWKNFQTLKI VILGLVLPLL VMVICYSGIL KTLLRCRNEK KRHR | ||||
Code | Name | Ratio | Code | Name | Ratio |
F | Phenylalanine | 2 (4.5%) | I | Isoleucine | 4 (9.1%) |
W | Tryptophan | 1 (2.3%) | V | Valine | 3 (6.4%) |
K | Lysine | 5 (11.4%) | C | Cysteine | 2 (4.5%) |
N | Asparagine | 2 (4.5%) | S | Serine | 1 (2.3%) |
Q | Glutamine | 1 (2.3%) | R | Arginine | 4 (9.1%) |
T | Threonine | 1 (2.3%) | H | Histidine | 1 (2.3%) |
L | Leucine | 7 (15.9%) | P | Proline | 1 (2.3%) |
M | Methionine | 1 (2.3%) | E | Glutamate | 1 (2.3%) |
G | Glycine | 1 (2.3%) | |||
Y | Tyrosine | 1 (2.3%) |
Gene variant | Frequency | Percentage (%) |
---|---|---|
Wild type (CCR5-wt) | 100 | 100 |
Mutant type (CCR5-Δ32) | 0 | 0 |
Strain | HIV-1 subtype |
---|---|
P1 | C |
P2 | C |
P3 | C |
P4 | C |
P5 | C |
P6 | C |
P7 | C |
P8 | C |
P9 | C |
P10 | C |
P11 | C |
P12 | C |